Serum apelin levels and cardiovascular diseases

Area of Science:

• Cardiovascular Science
• Endocrinology
• Molecular Biology

Background:

• Apelin is an endogenous ligand for G protein-coupled receptors.
• It is synthesized as a 77-amino acid pre-propeptide.
• Apelin expression is elevated in cardiovascular tissues, notably cardiomyocytes.

Purpose of the Study:

• To review the significance of apelin levels in cardiovascular diseases.
• To explore the potential of apelin as a therapeutic agent for blood pressure regulation and myocardial performance.
• To highlight the need for further investigation into the cardiovascular pathophysiology of apelin.

Main Methods:

• Literature review of existing studies on apelin and cardiovascular function.
• Analysis of apelin's role as a peripheral vasodilator and cardiac stimulant.
• Discussion of apelin's expression patterns in cardiovascular tissues.

Main Results:

• Apelin acts as a potent peripheral vasodilator.
• Apelin is a strong stimulant of ventricular contraction.
• Increased apelin expression is observed in various cardiovascular tissues.

Conclusions:

• Apelin holds therapeutic promise for managing blood pressure and improving myocardial performance.
• Understanding apelin's role in cardiovascular pathophysiology is essential.
• Further research is warranted to fully elucidate apelin's clinical applications in cardiovascular medicine.